Nuclear Medicine Europe
1.1 FTENuclear Medicine Europe reported total assets of 438,200 € at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Jul 2026), with 1.1 full-time equivalent.
By total assets for 2025, Nuclear Medicine Europe ranks in the top half of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Nuclear Medicine Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets -3 % Headcount (avg FTE) -39 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Nuclear Medicine Europe's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 22,407 € | ||||
| Equity | 181,000 € | ||||
| Cash | 232,745 € | ||||
| EBITDA | 36,199 € | ||||
| Total assets | 438,200 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jul 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 03 Jun 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 29 Jun 2022
Nuclear Medicine Europe's financial analysis
- Solvency41.3%sector median: 54.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Nuclear Medicine Europe
Nuclear Medicine Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0443.242.686
- VAT number
- BE0443242686
- Peppol
- Registered · 0208:0443242686 · as of 12 Nov 2026
- Incorporated
- 19 Feb 1991
- Registered office
- 1050 Ixelles
- Size
- Micro · 1.1 FTE
- Latest accounts
- 2025 · filed on 01 Jul 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
Nuclear Medicine Europe has been based in Ixelles since 1991, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 22,407 € and equity of 181,000 €; its revenue is not published. With 1.1 full-time equivalents, it is a micro-enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Nuclear Medicine Europe
Companies in the same business, of comparable size and area, outside its group.
- Van der Made Consulting Other business support service activities n.e.c. Ixelles · balance sheet 429,110 €
- Fastnet Other business support service activities n.e.c. Ixelles · balance sheet 448,693 €
- Heart Link Online Other business support service activities n.e.c. Roosdaal · balance sheet 428,190 €
- Taga Group Other business support service activities n.e.c. Wemmel · balance sheet 451,068 €
- BZG Other business support service activities n.e.c. Pont-à-Celles · balance sheet 437,143 €
- Hazel Other business support service activities n.e.c. Antwerp · balance sheet 439,527 €
- Conil Bruno Other business support service activities n.e.c. Frasnes-lez-Anvaing · balance sheet 435,636 €
- Lagoon Consult Other business support service activities n.e.c. Waterloo · balance sheet 435,035 €
Frequently asked questions about Nuclear Medicine Europe
What is the revenue of Nuclear Medicine Europe?
Nuclear Medicine Europe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Nuclear Medicine Europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0443242686 for Nuclear Medicine Europe, if the company is VAT-registered. Its company number (CBE) is 0443.242.686.
Where is the registered office of Nuclear Medicine Europe?
According to the CBE register, the registered office of Nuclear Medicine Europe is in 1050 Ixelles.
What is the equity of Nuclear Medicine Europe?
At the close of the 2025 financial year, the equity of Nuclear Medicine Europe amounts to 181,000 €, a solvency of 41.3% of total assets.
How many people work at Nuclear Medicine Europe?
1.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Nuclear Medicine Europe?
The register lists 5 active mandates at Nuclear Medicine Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Nuclear Medicine Europe within its sector?
By total assets for 2025, Nuclear Medicine Europe ranks in the top half of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year.
The full file of Nuclear Medicine Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →